Literature DB >> 20142309

MRI of the corpus callosum in multiple sclerosis: association with disability.

A Ozturk1, S A Smith, E M Gordon-Lipkin, D M Harrison, N Shiee, D L Pham, B S Caffo, P A Calabresi, D S Reich.   

Abstract

Inflammatory demyelination and axon damage in the corpus callosum are prominent features of multiple sclerosis (MS) and may partially account for impaired performance on complex tasks. The objective of this article was to characterize quantitative callosal MRI abnormalities and their association with disability. In 69 participants with MS and 29 healthy volunteers, lesional and extralesional callosal MRI indices were estimated via diffusion tensor tractography. expanded disability status scale (EDSS) and MS functional composite (MSFC) scores were recorded in 53 of the participants with MS. All tested callosal MRI indices were diffusely abnormal in MS. EDSS score was correlated only with age (r = 0.51). Scores on the overall MSFC and its paced serial auditory addition test (PASAT) and 9-hole peg test components were correlated with callosal fractional anisotropy (r = 0.27, 0.35, and 0.31, respectively) and perpendicular diffusivity (r = -0.29, -0.30, and -0.31) but not with overall callosal volume or callosal lesion volume; the PASAT score was more weakly correlated with callosal magnetization-transfer ratio (r = 0.21). Anterior callosal abnormalities were associated with impaired PASAT performance and posterior abnormalities with slow performance on the 9-hole peg test. In conclusion, abnormalities in the corpus callosum can be assessed with quantitative MRI and are associated with cognitive and complex upper-extremity dysfunction in MS.

Entities:  

Mesh:

Year:  2010        PMID: 20142309      PMCID: PMC2820126          DOI: 10.1177/1352458509353649

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  49 in total

1.  Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis.

Authors:  Jean-Philippe Ranjeva; Bertrand Audoin; My Van Au Duong; Sylviane Confort-Gouny; Irina Malikova; Patrick Viout; Elisabeth Soulier; Jean Pelletier; Patrick J Cozzone
Journal:  J Neurol Sci       Date:  2006-04-21       Impact factor: 3.181

2.  DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum.

Authors:  Hao Huang; Jiangyang Zhang; Hangyi Jiang; Setsu Wakana; Lidia Poetscher; Michael I Miller; Peter C M van Zijl; Argye E Hillis; Robert Wytik; Susumu Mori
Journal:  Neuroimage       Date:  2005-05-15       Impact factor: 6.556

3.  'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.

Authors:  Xia Lin; Christopher R Tench; Paul S Morgan; Graham Niepel; Cris S Constantinescu
Journal:  J Neurol Sci       Date:  2005-10-15       Impact factor: 3.181

4.  DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking.

Authors:  Hangyi Jiang; Peter C M van Zijl; Jinsuh Kim; Godfrey D Pearlson; Susumu Mori
Journal:  Comput Methods Programs Biomed       Date:  2006-01-18       Impact factor: 5.428

5.  Quantitative characterization of the corticospinal tract at 3T.

Authors:  D S Reich; S A Smith; C K Jones; K M Zackowski; P C van Zijl; P A Calabresi; S Mori
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

6.  Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis.

Authors:  Mark J Lowe; Craig Horenstein; Jochen G Hirsch; Ruth Ann Marrie; Lael Stone; Pallab K Bhattacharyya; Achim Gass; Micheal D Phillips
Journal:  Neuroimage       Date:  2006-06-23       Impact factor: 6.556

Review 7.  Cognitive impairment and decline in different MS subtypes.

Authors:  Stephan C J Huijbregts; Nynke F Kalkers; Leo M J de Sonneville; Vincent de Groot; Chris H Polman
Journal:  J Neurol Sci       Date:  2006-04-27       Impact factor: 3.181

8.  Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis.

Authors:  Jean-Philippe Ranjeva; Bertrand Audoin; My Van Au Duong; My Van Au Duong; Danielle Ibarrola; Sylviane Confort-Gouny; Irina Malikova; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick Cozzone
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

9.  Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum.

Authors:  Shu-Wei Sun; Hsiao-Fang Liang; Kathryn Trinkaus; Anne H Cross; Regina C Armstrong; Sheng-Kwei Song
Journal:  Magn Reson Med       Date:  2006-02       Impact factor: 4.668

Review 10.  Minimal neuropsychological assessment of MS patients: a consensus approach.

Authors:  Ralph H B Benedict; Jill S Fischer; Cate J Archibald; Peter A Arnett; William W Beatty; Julie Bobholz; Gordon J Chelune; John D Fisk; Dawn W Langdon; Lauren Caruso; Fred Foley; Nicholas G LaRocca; Lindsey Vowels; Amy Weinstein; John DeLuca; Stephen M Rao; Frederick Munschauer
Journal:  Clin Neuropsychol       Date:  2002-08       Impact factor: 3.535

View more
  65 in total

1.  Functional regression via variational Bayes.

Authors:  Jeff Goldsmith; Matt P Wand; Ciprian Crainiceanu
Journal:  Electron J Stat       Date:  2011-01-01       Impact factor: 1.125

2.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

3.  A novel PET marker for in vivo quantification of myelination.

Authors:  Chunying Wu; Changning Wang; Daniela C Popescu; Wenxia Zhu; Eduardo A Somoza; Junqing Zhu; Allison G Condie; Christopher A Flask; Robert H Miller; Wendy Macklin; Yanming Wang
Journal:  Bioorg Med Chem       Date:  2010-11-09       Impact factor: 3.641

4.  Diffuse and focal corticospinal tract disease and its impact on patient disability in multiple sclerosis.

Authors:  Fernanda Tovar-Moll; Iordanis E Evangelou; Annie W Chiu; Sungyoung Auh; Christina Chen; Mary Ehrmantraut; Joan M Ohayon; Nancy Richert; Francesca Bagnato
Journal:  J Neuroimaging       Date:  2014-10-16       Impact factor: 2.486

5.  Parametrization of white matter manifold-like structures using principal surfaces.

Authors:  Chen Yue; Vadim Zipunnikov; Pierre-Louis Bazin; Dzung Pham; Daniel Reich; Ciprian Crainiceanu; Brian Caffo
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

6.  Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.

Authors:  Jiwon Oh; Shiv Saidha; Min Chen; Seth A Smith; Jerry Prince; Craig Jones; Marie Diener-West; Peter C M van Zijl; Daniel S Reich; Peter A Calabresi
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

7.  LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS.

Authors:  Snehashis Roy; Aaron Carass; Navid Shiee; Dzung L Pham; Peter Calabresi; Daniel Reich; Jerry L Prince
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2013

8.  Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.

Authors:  Anne-Marie Ternes; Jerome J Maller; Joanne Fielding; Patricia Addamo; Owen White; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

9.  Automated vs. conventional tractography in multiple sclerosis: variability and correlation with disability.

Authors:  Daniel S Reich; Arzu Ozturk; Peter A Calabresi; Susumu Mori
Journal:  Neuroimage       Date:  2009-11-26       Impact factor: 6.556

10.  Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.

Authors:  Daniel M Harrison; Navid Shiee; Pierre-Louis Bazin; Scott D Newsome; John N Ratchford; Dzung Pham; Peter A Calabresi; Daniel S Reich
Journal:  J Neurol       Date:  2012-08-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.